Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic effects of α-L-Guluronic acid in patients with rheumatoid arthritis
IRCT2016092813739N5Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of guluronic acid in rheumatoid arthritis (RA), sponsored by Tehran University of Medical Sciences. Started Nov 2016; status: completed.
02
Drugs
guluronic acid
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on IRCT2016092813739N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016092813739N5.